254 related articles for article (PubMed ID: 16523015)
1. Survival and prognostic variables of cutaneous melanoma observed between 1995 and 2000 at Istituto Dermopatico Dell'Immacolata (IDI-IRCCS), Rome, Italy.
Fortes C; Mastroeni S; Sera F; Concolino F; Abeni D; Melchi F; Forastiere F; Pasquini P
Eur J Cancer Prev; 2006 Apr; 15(2):171-7. PubMed ID: 16523015
[TBL] [Abstract][Full Text] [Related]
2. Time trends in features of cutaneous melanoma at diagnosis: central-south Italy, 1962-1991.
Cavalieri R; Macchini V; Mostaccioli S; Sonego G; Ferranti G; Corona R; Fucci M; Marzolini F; Rosmini F; Pasquini P
Ann Ist Super Sanita; 1993; 29(3):469-72. PubMed ID: 8172468
[TBL] [Abstract][Full Text] [Related]
3. Prognostic variables and prognostic groups for malignant melanoma. The information from Cox and Classification And Regression Trees analysis: an Italian population-based study.
Crocetti E; Mangone L; Lo Scocco G; Carli P
Melanoma Res; 2006 Oct; 16(5):429-33. PubMed ID: 17013092
[TBL] [Abstract][Full Text] [Related]
4. Thick cutaneous malignant melanoma: a reappraisal of prognostic factors.
Massi D; Borgognoni L; Franchi A; Martini L; Reali UM; Santucci M
Melanoma Res; 2000 Apr; 10(2):153-64. PubMed ID: 10803716
[TBL] [Abstract][Full Text] [Related]
5. Changing biology of cutaneous melanoma.
Peric B; Zgajnar J; Besic N; Hocevar M
Melanoma Res; 2008 Jun; 18(3):225-9. PubMed ID: 18477898
[TBL] [Abstract][Full Text] [Related]
6. Development of prognostic factors and survival in cutaneous melanoma over 25 years: An analysis of the Central Malignant Melanoma Registry of the German Dermatological Society.
Buettner PG; Leiter U; Eigentler TK; Garbe C
Cancer; 2005 Feb; 103(3):616-24. PubMed ID: 15630700
[TBL] [Abstract][Full Text] [Related]
7. Predicting ten-year survival of patients with primary cutaneous melanoma: corroboration of a prognostic model.
Sahin S; Rao B; Kopf AW; Lee E; Rigel DS; Nossa R; Rahman IJ; Wortzel H; Marghoob AA; Bart RS
Cancer; 1997 Oct; 80(8):1426-31. PubMed ID: 9338466
[TBL] [Abstract][Full Text] [Related]
8. Survival and prognostic factors in patients with localised cutaneous melanoma observed between 1980 and 1991 at the Istituto Dermopatico dell'Immacolata in Rome, Italy.
Corona R; Sciò M; Mele A; Ferranti G; Mostaccioli S; Macchini V; Sonego G; Ferrigno L; Fucci M; Osborn JF
Eur J Cancer; 1994; 30A(3):333-8. PubMed ID: 8204355
[TBL] [Abstract][Full Text] [Related]
9. Gene expression profiling of primary cutaneous melanoma and clinical outcome.
Winnepenninckx V; Lazar V; Michiels S; Dessen P; Stas M; Alonso SR; Avril MF; Ortiz Romero PL; Robert T; Balacescu O; Eggermont AM; Lenoir G; Sarasin A; Tursz T; van den Oord JJ; Spatz A;
J Natl Cancer Inst; 2006 Apr; 98(7):472-82. PubMed ID: 16595783
[TBL] [Abstract][Full Text] [Related]
10. A ten-year analysis of demographic trends for cutaneous melanoma: analysis of 2501 cases treated at the University Department of Dermatology in Vienna (1990-1999).
Kittler H; Binder M; Wolff K; Pehamberger H
Wien Klin Wochenschr; 2001 Apr; 113(9):321-7. PubMed ID: 11388077
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors for survival after enucleation for choroidal and ciliary body melanomas.
Isager P; Ehlers N; Overgaard J
Acta Ophthalmol Scand; 2004 Oct; 82(5):517-25. PubMed ID: 15453846
[TBL] [Abstract][Full Text] [Related]
12. Improved survival for melanoma in Northern Ireland: a comparison of two 5-year periods (1984-88 and 1994-98).
McMullen EA; Kee F; Patterson CC; Gavin AT; Dolan OM
Br J Dermatol; 2004 Sep; 151(3):587-93. PubMed ID: 15377344
[TBL] [Abstract][Full Text] [Related]
13. Is head and neck melanoma a distinct entity? A clinical registry-based comparative study in 5702 patients with melanoma.
Hoersch B; Leiter U; Garbe C
Br J Dermatol; 2006 Oct; 155(4):771-7. PubMed ID: 16965427
[TBL] [Abstract][Full Text] [Related]
14. Epidemiological features and prognostic factors of cutaneous head and neck melanoma: a population-based study.
Golger A; Young DS; Ghazarian D; Neligan PC
Arch Otolaryngol Head Neck Surg; 2007 May; 133(5):442-7. PubMed ID: 17515502
[TBL] [Abstract][Full Text] [Related]
15. A population-based study of cutaneous melanoma in Alberta, Canada (1993-2002).
Metelitsa AI; Dover DC; Smylie M; de Gara CJ; Lauzon GJ
J Am Acad Dermatol; 2010 Feb; 62(2):227-32. PubMed ID: 20018405
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of patients with local recurrence of cutaneous malignant melanoma: a population-based study.
Cohn-Cedermark G; Månsson-Brahme E; Rutqvist LE; Larsson O; Singnomklao T; Ringborg U
Cancer; 1997 Oct; 80(8):1418-25. PubMed ID: 9338465
[TBL] [Abstract][Full Text] [Related]
17. Risk and survival of cutaneous melanoma diagnosed subsequent to a previous cancer.
Yang GB; Barnholtz-Sloan JS; Chen Y; Bordeaux JS
Arch Dermatol; 2011 Dec; 147(12):1395-402. PubMed ID: 22184761
[TBL] [Abstract][Full Text] [Related]
18. Clinical and histopathological risk factors to predict sentinel lymph node positivity, disease-free and overall survival in clinical stages I-II AJCC skin melanoma: outcome analysis from a single-institution prospectively collected database.
Mandalà M; Imberti GL; Piazzalunga D; Belfiglio M; Labianca R; Barberis M; Marchesi L; Poletti P; Bonomi L; Novellino L; Di Biagio K; Milesi A; Guerra U; Tondini C
Eur J Cancer; 2009 Sep; 45(14):2537-45. PubMed ID: 19553103
[TBL] [Abstract][Full Text] [Related]
19. Invasive cutaneous malignant melanoma in Sweden, 1990-1999. A prospective, population-based study of survival and prognostic factors.
Lindholm C; Andersson R; Dufmats M; Hansson J; Ingvar C; Möller T; Sjödin H; Stierner U; Wagenius G;
Cancer; 2004 Nov; 101(9):2067-78. PubMed ID: 15372475
[TBL] [Abstract][Full Text] [Related]
20. Acral lentiginous melanoma: a clinicoprognostic study of 126 cases.
Phan A; Touzet S; Dalle S; Ronger-Savlé S; Balme B; Thomas L
Br J Dermatol; 2006 Sep; 155(3):561-9. PubMed ID: 16911282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]